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ABSTRACT
Objective To investigate basic assumptions and other
methodological problems in the application of indirect
comparison in systematic reviews of competing
healthcare interventions.
Design Survey of published systematic reviews.
Inclusion criteria Systematic reviews published between
2000 and 2007 in which an indirect approach had been
explicitly used.
Data extraction Identified reviews were assessed for
comprehensiveness of the literature search, method for
indirect comparison, and whether assumptions about
similarity and consistency were explicitly mentioned.
Results The survey included 88 review reports. In 13
reviews, indirect comparison was informal. Results from
different trials were naively compared without using a
common control in six reviews. Adjusted indirect
comparison was usually done using classic frequentist
methods (n=49) or more complex methods (n=18). The key
assumption of trial similarity was explicitly mentioned in
only 40 of the 88 reviews. The consistency assumption was
notexplicitinmostcaseswheredirectandindirectevidence
were compared or combined (18/30). Evidence from head
to head comparison trials was not systematically searched
for or not included in nine cases.
Conclusions Identified methodological problems were an
unclear understanding of underlying assumptions,
inappropriate search and selection of relevant trials, use
of inappropriateor flawed methods, lack of objective and
validated methods to assess or improve trial similarity,
and inadequate comparison or inappropriate
combination of direct and indirect evidence. Adequate
understanding of basic assumptions underlying indirect
and mixed treatment comparison is crucial to resolve
these methodological problems.
Appendix 1 PubMed search strategy
Appendix 2 Characteristics of identified reports
Appendix 3 Identified studies
References of included studies
INTRODUCTION
The number of available healthcare interventions
increases with time, reflecting advances in science
and technology. For many clinical indications clini-
cians may have to choose among several competing
interventions. In this era of evidence based decision
making, relative effectiveness and cost effectiveness
of different interventions need to be objectively and
accurately assessed in clinical studies. It has been
accepted generally that well designed and implemen-
ted head to head randomised controlled trials provide
the most rigorous and valid research evidence on the
relative effects of different interventions.
1 Evidence
from head to head comparison trials is often limited
or unavailable, however, and indirect comparison
may therefore be necessary.
23
Indirect comparison may be done narratively—for
example,bydiscussingtheresultsofseparatesystema-
tic reviews of different interventions for a given condi-
tion.Asimplebutinappropriatestatisticalmethodisto
compare the results of individual arms from different
trials as if they were from the same randomised con-
trolledtrial.This naive or unadjustedindirectcompar-
ison has been criticised for discarding the within trial
comparison, increasing liability to bias and over-pre-
ciseestimates.
2Incontrasttosuchanaiveindirectcom-
parison, the adjusted indirect comparison can take
advantage of the strength of randomised controlled
trials in making unbiased comparisons.
45 Here the
indirect comparison of different interventions is
adjusted by comparing the results of their direct com-
parisons with a common control group.
Box1providesanexampleofadjustedindirectcom-
parison. The case study involves a comparison of
bupropion and nicotine replacement therapy patch
for smoking cessation, based on a direct comparison
trial
6andanadjustedindirectcomparisonusing21pla-
cebo controlled trials.
7
Indirect comparison
The results of placebo controlled trials suggested that
both bupropion and nicotine replacement therapy are
moreeffectivethanplaceboforsmokingcessation.The
results of the two sets of placebo controlled trials can
also be used to indirectly compare bupropion with
nicotine replacement therapy patch. The magnitude
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cebo (odds ratio 0.51, 95% confidence interval 0.36 to
0.73) was similar to that of nicotine replacement ther-
apycomparedwithplacebo(0.57,0.48to0.67).There-
fore it could be indirectly concluded that bupropion
was as effective as nicotine replacement therapy. The
adjusted indirect comparison can also be formally
done, using one of several methodologically sound
methods. The result of adjusted indirect comparison
suggests that bupropion was as effective as nicotine
replacement therapy for smoking cessation (0.90,
0.61 to 1.34), although the confidence interval is
wide. The validity of the adjusted indirect comparison
depends on a similarity assumption, which assumes
that the two sets of placebo controlled trials are suffi-
ciently similar for moderators of relative treatment
effect.
Comparison of direct and indirect estimates
The result of the head to head comparison trial sug-
gestedthatbupropionwasmoreeffectivethannicotine
replacement therapy for smoking cessation (0.48, 0.28
to 0.82), which is different from the result of adjusted
indirect comparison (0.90, 0.61 to 1.34). The discre-
pancy between the direct and indirect estimate was
marginally statistically significant (I
2=71%, P=0.06).
Statisticalmethodsareavailabletocombinetheresults
of direct and indirect evidence (combined odds ratio
0.68, 95% confidence interval 0.37 to 1.25). A consis-
tencyassumptionis,however,requiredtocombinethe
directandindirectestimate.Thecombinationofincon-
sistent evidence from different sources may provide
invalid and misleading results.
To improve statistical power evidence generated by
indirect comparison can be combined with evidence
from head to head trials.
8-10 The combination of direct
andindirectevidencehasbeenfacilitatedbythedevel-
opment of network meta-analysis
11 and Bayesian hier-
archical models for mixed treatment comparisons.
12
These methods are especially helpful when the rele-
vant trials have considered many different treatments.
Available empirical evidence indicates that the
results of an adjusted indirect comparison usually but
not always agree with the results of direct comparison
trials.
4 Recently, conflicting evidence has emerged
about the validity of indirect comparison. For
example, a report of three case studies suggested that
adjusted indirect comparison may be less biased than
headtoheadtrialsforevaluatingnewdrugs.
7Onetrial,
however, concluded that “indirect comparisons could
be unreliable for complex and rapidly evolving inter-
ventions” such as initial highly active antiretroviral
therapy.
13 Therefore the potential usefulness of
adjusted indirect comparison is still overshadowed by
concern about bias resulting from its misuse.
Existing statistical methods for adjusted indirect
comparison and mixed treatment comparison are
unbiased, but only if some assumptions are fulfilled.
2
One study described the assumption for indirect com-
parison as the constant treatment effect “across differ-
ences in the populations’ baseline characteristics.”
5
The only requirement mentioned by another study
was that the populations of the individual studies con-
tain some subpopulation in common.
14 Therefore the
description of important assumptions underlying
indirect comparison may not be clear in some metho-
dological studies. For mixed treatment comparison it
was noted that “the only additional assumption is that
the similarity of the relative effects of treatment holds
acrosstheentiresetoftrials,irrespectiveofwhichtreat-
ments were actually evaluated.”
8 The additional
assumption may hold to a subset of trials, although it
may not be the case across the entire set of trials. For
instance, an indirect comparison may be valid but its
result may not be consistent with the result of a direct
comparison.
7 Therefore we suggest a framework to
delineate the main assumptions related to indirect
and mixed treatment comparison (fig 1).
In standard meta-analysis of randomised trials it is
assumed that different trials are sufficiently (not neces-
sarily completely) homogeneous and that they esti-
mate the same single treatment effect (fixed effect
model) or different treatment effects distributed
around a typical value (random effects model).
1516
Werefer tothisassumptionforstandardmeta-analysis
as the homogeneity assumption, to distinguish it from
other related assumptions. In adjusted indirect com-
parison,thehomogeneityassumptionforconventional
meta-analysis should be fulfilled when multiple trials
are involved. For the example in box 1, the nine pla-
cebocontrolledtrialsofbupropionshouldbehomoge-
neous enough to be pooled in meta-analysis; and the
same for the 19 placebo controlled trials of nicotine
replacement therapy.
In addition to the homogeneity assumption, a simi-
larityassumptionisrequiredforadjustedindirectcom-
parison—namely, thattrialsare similar formoderators
of relative treatment effect.
25 That is, for the indirect
comparison of bupropion compared with nicotine
replacement therapy based on the common placebo
control (box 1), the average relative effect estimated
by placebo controlled trials of bupropion should be
generalisable to patients in placebo controlled trials
of nicotine replacement therapy, and vice versa. Trial
similarity could be considered from two perspectives:
clinical similarity and methodological similarity. Clin-
ical similarity refers to similarity in patients’
Pooling of trials
comparing intervention
A with C
Adjusted indirect comparison of trial comparing intervention
A with B, using intervention C as common comparator
Comparison or combination of direct and indirect
estimates for comparing intervention A with B
Pooling of trials
comparing intervention
B with C
Pooling of trials
comparing intervention
A with B
Homogeneity
Homogeneity and
similarity of trial
Homogeneity,
similarity of trial,
and consistency
of evidence
Levels of
assumptions
Two sets of trials used in
adjusted indirect comparison
Head to head
comparison trials
Fig 1 | Assumptions underlying adjusted indirect and mixed treatment comparison
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up, and outcomes measured. Methodological similar-
ity refers to aspects of trials associated with the risk of
bias. It is mathematically proved that adjusted indirect
comparisonmaycounterbalancebiasintrialsand pro-
vide an unbiased estimate, if the two sets of trials are
similarly biased.
7
A further assumption of consistency is required to
combineresultsofdirectandadjustedindirectcompar-
ison using fixed effect or random effects model.
21117
Even when the adjusted indirect comparison is valid,
the indirect evidence may not be consistent with evi-
dence from head to head trials because of clinically
meaningful heterogeneity.
57 For the case study of
bupropion compared with nicotine replacement ther-
apy for smoking cessation box 1), the result of the
direct comparison was different from that of the
adjusted indirect comparison (I
2=71%, P=0.06). The
discrepancy between the direct and indirect estimate
may result from several possible causes, including the
playofchance,invalidindirectcomparison,biasinthe
headto headcomparisontrial,andclinicallymeaning-
ful heterogeneity across trials. For example, trials that
evaluate new drugs may include patients who had
responded poorly to old drugs. If the response to the
newdrugisnotaffectedbythepoorresponsetotheold
drug, the results of direct comparison of new and old
drugs will be applicable only to patients who had a
poor response to the old drugs, whereas the adjusted
indirect comparison may be more generalisable to
patients in general.
Comparisons and related assumptions may need to
be further expanded when multiple sets of trials are
involved in indirect comparison. For instance, the
adjusted indirect comparison of intervention A with
B could be done using trials that compared inter-
vention A with D and those that compared inter-
vention B with D as well as trials that compared
intervention A with C and those that compared inter-
vention B with C. A consistency assumption is neces-
sary to pool the results from different indirect
comparisons. Because of increased complexity of the
data structure, assumptions additional to those out-
linedinfigure1mayberequiredformanymixedtreat-
ment comparisons.
2
In summary, assumptions concerning adjusted
indirect comparison and mixed treatment comparison
are similar to but more complex than the underlying
assumption for standard meta-analysis. At least three
issuesofcomparabilityneedtobeconsidered:ahomo-
geneityassumptionforeachmeta-analysis,asimilarity
assumption for individual adjusted indirect compari-
son,andaconsistencyassumptionforthecombination
of evidence from different sources (fig 1). The three
issues of comparability concern the different levels of
decisions for a research synthesis of clinical trials. The
trial similarity assumption for adjusted indirect com-
parisonisrelevantonlyifthehomogeneityassumption
isvalid;andtheconsistencyassumptionneedsthepre-
requisite of both the homogeneity assumption and the
similarity assumption (fig 1).
We reportfindingsfroma surveyofmethodological
problemsintheapplicationofindirectandmixedtreat-
ment comparison. We determined which methods
have been used for indirect comparison and what
methodological problems can be identified in these
applications of indirect comparison.
METHODS
We searched PubMed for systematic reviews or meta-
analyses published between 2000 and 2007 in which
indirect comparison had been explicitly used accord-
ing to the titles or abstracts. The search strategy (see
web extra appendix 1) was developed on the basis of
our previous work
2 and modified after comparing the
results of a preliminary searchwith some known refer-
ences.Keytermsusedwere“adjustedindirectcompar-
ison”, “indirect” or “indirectly”, “network meta-
analysis”, “mixed treatment”, “multiple treatment”,
“multiple comparison”, “cross-trial”, and “cross-
study”. We limited the search to systematic reviews
by combining the above terms with “meta-analysis”
or “systematic[sb]”. The literature search was done
first in May 2007 and then updated in October 2008,
Box 1: A simple example of indirect comparison
The case study involves a comparison of bupropion with nicotine replacement therapy
patch for smoking cessation.
7 The outcome was the number of smokers who failed to quit
at 12 months (table). Indirect comparison can be made using two sets of randomised
controlled trials: nine trials that compared bupropion with placebo and 19 that compared
nicotine replacement therapy with placebo. One trial also directly compared bupropion
with nicotine replacement therapy.
6
Number of smokers failing to quit at 12 months, according to treatment group
Comparison
No of
trials Odds ratio (95% CI) I2 (%)
Bupropion v placebo 9 0.51 (0.36 to 0.73) 54
NRT patch v placebo 19 0.57 (0.48 to 0.67) 12
Bupropion v NRT patch:
Direct comparison 1 0.48 (0.28 to 0.82) —
Adjusted indirect
comparison
9+19 0.90 (0.61 to 1.34) —
Combined (direct
+indirect)
1+(9+19) 0.68 (0.37 to 1.25) 71
NRT=nicotine replacement therapy.
See Bucher et al
5 and Song et al
4 for indirect comparison methods. Random effects model was used in
meta-analyses of trials and for combination of direct and indirect estimates.
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Fig 2 | Publication year of 88 review reports that explicitly
used indirect comparison
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abstracts of the retrieved references were indepen-
dentlyassessedbytworeviewerstoidentifysystematic
reviews or meta-analyses of randomised controlled
trials in which indirect comparison was explicitly
used in the comparison of different healthcare inter-
ventions.
Full publications were obtained for systematic
reviews identified on the basis of the titles or abstracts.
After examining full publications we excluded reports
in which primary studies were not randomised con-
trolled trials, indirect comparison had not been done,
or the articles were editorial style reviews. We also
excluded duplicate publications of the same reports
or considered them as one. For Cochrane reviews we
used the most recent update, although the earliest ver-
sion since 2000 is also cited.
Fromtheincludedreportsweextracteddataonclin-
ical indications, interventions compared, comprehen-
siveness of the literature search for trials used in
indirectcomparison,methodsforindirectcomparison,
and whether direct evidence from head to head com-
parison trials was also available. We examined
whether the assumption of similarity was explicitly
mentioned and whether any efforts were made to
investigate or improve the similarity of trials for indir-
ect comparison. One reviewer (FS) extracted data and
another reviewer (YL, A-MG, or TW) checked each
study. Extracted data were summarised in tables and
narratively described.
RESULTS
Overall, 88 review reports (91 publications) in which
an indirect comparison was explicitly done (see web
extra appendix 2 for the main characteristics of the
included reports
w1-w91) were included. Fifty nine were
reviews of effectiveness of interventions published in
journals, 19 were reports of health technology assess-
ment or cost effectiveness analysis, six were Cochrane
systematicreviews,andfourwerereviewsusedtoillus-
trate methods for indirect comparisons.
Indirect comparison has become increasingly or
more explicitly used in research syntheses for the eva-
luation of a wide range of healthcare interventions
(figs2and3).Indirectcomparisonwasusedtoevaluate
drug interventions in 72 of the 88 reviews. Of the 72
drug assessments, 43 compared drugs of different
classes, 17 compared drugs of the same class, and 10
compareddifferentformatsormodesofdeliveryofthe
samedrug.Tworeviewscomparedtherelativeefficacy
of an active drug with placebo. Non-drug inter-
ventions, including counselling, devices, and surgical
or diagnostic procedures, were indirectly compared in
16 reviews.
The most commonly usedapproach(49/88) wasthe
adjusted indirect comparison using classic frequentist
methods (table 1). More complex methods (including
network or Bayesian hierarchical meta-analysis and
mixed treatment comparison methods) were used in
18 reviews. In 13 reviews, indirect comparison was
informal, without calculation of relative effects or test-
ing for statistical significance. In six reviews results
from different trials were naively compared without
using a common treatment control.
Most indirect comparisons (n=67) used outcome
measures for categorical data, including odds ratio,
risk difference, relative risk, or hazard ratio. Outcome
measuresforcontinuousdata(meandifferenceorstan-
dardisedmeandifference)wereusedin13reviews,and
eight reviews measured both categorical and continu-
ous outcomes.
Directevidencefromheadtoheadcomparisontrials
was available in 40 of the 88 reviews (see web extra
appendix 3), including 15 reviews that used simple
adjusted methods, 16 that used more complex meth-
ods,and six that usedinformal methods.Ascompared
withsimple adjustedmethods,complexmethodswere
more likely to be used to combine the direct and indir-
ect evidence. Where direct comparison was available,
direct and indirect evidence were combined in 15 of
the 16 reviews that used complex methods and in
only two of the 15 reviews that used simple methods
(table 1). Furthermore, direct and indirect evidence
were less likely to be explicitly compared in reviews
thatusedcomplexmethodsthaninthosethatusedsim-
ple methods (9/16 v 11/15).
The assumption of trial similarity was explicitly
mentioned or discussed in only 40 of the 88 reviews
(table 2).Explicitmentionofthesimilarityassumption
was associated with efforts to examine or improve the
similarity between trials for indirect comparisons (30/
40 v 19/48). Methods to investigate or improve trial
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Fig 3 | Types of interventions indirectly compared in 88 review
reports
Table 1 |Methods used for indirect comparison and availability of direct comparison evidence
Indirect comparison
method
No (%) of included
reviews
Direct comparison
available
Comparison of
indirect and direct
evidence
Combination of
indirect and direct
evidence
Simple adjusted 49 (56) 15 11 2
Network or Bayesian
approaches
18 (20) 16 9 15
Informal indirect 13 (15) 6 1 0
Naive indirect 6 (7) 2 1 0
Unclear 2 (2) 1 1 0
Total 88 (100) 40 24 17
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ison of study characteristics (n=26) and subgroup and
metaregression analysis to identify or adjust for possi-
ble moderators of treatment effects (n=23). The
assumption of consistency was not explicit in most
cases where direct and indirect evidence were com-
pared or combined (18/30; table 3).
In eight of the 88 reviews, indirect comparison was
basedondatafromotherpublishedsystematicreviews
ormeta-analyses(seewebextraappendix2).Evidence
from head to head comparison trials was not system-
atically searched for or not included in nine cases (see
web extra appendix 2).
DISCUSSION
Indirect comparison is being increasingly (or more
explicitly) used for the evaluation of a wide range of
healthcare interventions. The need for indirect com-
parisonismoreapparentintheassessmentofeffective-
ness and cost effectiveness of healthcare interventions
tosupportclinicalandpolicydecisionmaking.Sixteen
of the 88 included reviews were health technology
assessment reports. In many such reports, indirect
comparison had not been done in relation to clinical
effectiveness but was used in the economic evaluation.
Researchers may have to use whatever data are avail-
able to estimate the incremental cost effectiveness of
competing interventions.
Intheexistingliterature,severalrelatedbutdifferent
assumptions underlying adjusted indirect comparison
(fig 1) have not been clearly distinguished, resulting in
somemethodologicalandpracticalproblemsintheuse
andinterpretationofindirectormixedtreatmentcom-
parison. The identified problems include unclear
understandingofunderlyingassumptions,inappropri-
ate search and selection of relevant trials, use of inap-
propriate or flawed methods, lack of objective and
validatedmethodstoassessorimprovetrialsimilarity,
and inadequate comparison or inappropriate combi-
nation of direct and indirect evidence.
What methods should be used for indirect comparison?
Indirect comparison was explicit but informal in 13
review reports. Informal indirect comparison means
that neither relative effects nor statistical significance
wereformallycalculated.Sincetheuseofindirectcom-
parison is often inevitable, a more explicit and formal
approach is preferable to implicit and informal
approaches. In six reviews of randomised controlled
trials,theresultsfromindividualarmsofdifferenttrials
were compared naively as if they were from a single
controlled trial. This naive indirect comparison is
methodologically flawed because the strength of ran-
domisation is totally disregarded.
2
Thestrengthofrandomisationcouldbepreservedin
adjusted indirect comparison. The methods for simple
adjusted indirect comparison have been described in
severalarticles.
5141819Themostcommonscenariowas
the indirect comparison of two competing inter-
ventions adjustedby common comparatorsusing clas-
sic frequentist methods (including simple
metaregression). The advantages of the simple meth-
ods include ease of use and transparency. However,
when there are several alternative interventions to be
compared, the simple adjusted indirect comparison
may become rather tedious and inconvenient. More
complex methods, including network meta-analysis
and Bayesian hierarchical models, which can be used
to make simultaneous comparisons of multiple inter-
ventions, have been increasingly used.
91112 These
methodstreatallincludedinterventionsequallyrather
than focusing on one particular comparison of two
interventions.
Table 2 |Similarity assumptions and efforts to examine or improve similarity of trials used in
indirect comparison
Explicit similarity
assumption
Efforts reported
Efforts not
reported Total
Subjective
judgment
Subgroup or
metaregression analysis
Y e s 1 61 41 0 4 0
No 10 9 29 48
Total 26 23 39 88
Box 2: Main methodological problems in using indirect comparison and
recommendations
Methodological problems
 Unclear understanding of underlying assumptions
 Incomplete search and inclusion of relevant studies
 Use of flawed or inappropriate methods
 Lack of objective and validated methods to assess or improve trial similarity
 Inadequate comparison and inappropriate combination of direct and indirect evidence
Recommendations
 More explicit and elaborate description and discussion of underlying assumptions in
methodological studies and in systematic reviews in which different interventions are
indirectly compared
 Literature search needs to be systematic in order to identify all relevant studies
 The evidence from head to head comparison trials should not be excluded in reviews
that use indirect comparison
 The availability of all active treatment controlled studies that are suitable for adjusted
indirect comparison should be explicitly discussed, and justifications provided if only
placebo controlled trials are used for adjusted indirect comparison
 Naive indirect comparison of different arms from different trials should be avoided
 Data from trials with multiple arms should be appropriately analysed, to avoid both
downgrading direct evidence and using the same control group more than once in
adjusted indirect comparison
 Methods for investigating heterogeneity in standard meta-analysis can be adopted to
assess trial similarity in adjusted indirect comparison, including subgroup analysis,
metaregression, and experts’ subjective judgment. However, further research is
needed
 Direct and indirect evidence should be separately presented and explicitly compared,
whether or not the two sets of data are subsequently combined
 Possible reasons for any observed discrepancies between direct and indirect evidence
should be investigated
 The consistency assumption should be explicitly assessed before direct evidence is
combined with indirect evidence
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Awareness of the assumption of trial similarity is asso-
ciated with increased efforts to investigate or improve
trial similarity for adjusted indirect comparison. Sub-
groupanalysisandmetaregressionarecommonlyused
methods to assess or improve trial similarity for
adjustedindirectcomparison(table 2).Trialsincluded
in subgroup analyses are homogeneous for certain
variables at study level, whereas indirect comparison
couldbefurtheradjustedwithselectedstudylevelvari-
ables in metaregression analysis. However, the useful-
ness of subgroup analysis and metaregression may be
ratherlimited because the number of trialsinvolved in
adjusted indirect comparison was usually small and it
was uncertain whether the important study level vari-
ables were reported in all relevant trials.
Trialsimilaritywasoftenassessedbyexamininghet-
erogeneity across trials and by a narrative comparison
of trial characteristics for the different treatment com-
parisons being included, which may be deemed infor-
mal and subjective. One study noted that the
assumptions underlying mixed treatment comparison
“are unlikely to be statistically verifiable, and it seems
reasonabletorelyonexpertclinicalandepidemiologi-
cal judgment.”
8 Because of lack of transparency, how-
ever, it is unclear to what extent we could trust the
reported judgment that trials were similar enough for
an adjusted indirect comparison. Further research is
needed in this area.
When both direct and indirect evidence are available
When data from head to head comparison trials are
available, several important things need to be consid-
ered. Firstly, whether the use of indirect comparison is
justified when direct comparison trials are available.
Secondly, any discrepancies between direct and indir-
ect evidence need to be interpreted sensibly. Thirdly,
according to answers to the second question, whether
direct evidence could be combined with the results of
indirect comparison.
Itiscontroversialwhetherindirectevidenceneedsto
beconsideredwhenthereisevidencefromdirectcom-
parison trials.
58 Indirect comparison was seemingly
considered still to be helpful by authors of the 40
reviews in which both direct and indirect evidence
were available. Handling of the second and the third
questionsseemedtoreflectthechoiceofmethodsused
for indirect comparison. Direct and indirect evidence
were less likely to be explicitly compared and more
likely tobe combinedin review reportsthat usedcom-
plex methods (network meta-analysis or mixed treat-
ment comparison), as compared with simple adjusted
indirect comparisons (table 1). Since the assumptions
underlying mixed treatment comparison are much
more arduous to verify than simple adjusted indirect
comparison (fig 1), it seems odd that the comparison
of direct and indirect evidence has not been more
explicitly done in many published mixed treatment
comparisons or network meta-analyses (table 1). The
importance of investigating incoherence or inconsis-
tency in the evidence network has been
emphasised.
1117 Since the evidence consistency is
usuallyassessedinformallyandsubjectively,
8transpar-
ency is important to allow others to make their own
judgment according to explicitly presented discrepan-
cies. In the practice of research synthesis, the use of
complex methodsneedsto focus more onthe compar-
ison of evidence from different sources.
Reviewreportsmayincludetrialswiththreeormore
arms. For example, the trial that directly compared
bupropion and nicotine replacement therapy (see
box 1) also has a placebo arm.
6 Some review reports
separately compared the two active treatments with
placebo within the same trial, and then the results of
two separate comparisons were used in adjusted indir-
ect comparison. This is methodologically inappropri-
ate because it downgrades direct evidence to indirect
evidence, reduces precision, and uses data from the
same placebo arm twice. Evidence from head to head
comparisontrialsshouldbeclearlyseparatedfromevi-
dence based on indirect approaches.
Literature search and study inclusion
Reviewed reports of indirect comparison often men-
tioned that no head to head comparison trials were
available, but in some cases the availability of direct
evidence was uncertain. In nine of the 88 reviews,
directcomparisontrialswereexcludedornotsearched
for systematically. It is worrying that direct evidence
has sometimes been disregarded without good justifi-
cation.
In review reports that included only placebo con-
trolled trials, it was often unclear whether there were
other active treatment controlled trials that could also
be used for adjusted indirect comparison. For
Table 3 |Consistency assumption when direct and indirect evidence were compared or
combined
Compared or combined direct and
indirect evidence
Consistency assumption
Total Explicit Not explicit
Yes 12 18 30
No 0 10 10
Total 12 28 40
WHAT IS ALREADY KNOWN ON THIS TOPIC
Indirect comparisons can be valid if some basic
assumptions are fulfilled
Therelated but different methodologicalassumptions have
not been clearly distinguished
WHAT THIS STUDY ADDS
Certainmethodologicalproblemsmayinvalidatetheresults
of evaluations using indirect comparison approaches
Understanding basic assumptions underlying indirect and
mixed treatment comparison is crucial to resolve these
problems
A framework can help clarify homogeneity, similarity, and
consistency assumptions underlying adjusted indirect
comparisons
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ect comparison should include not only placebo con-
trolled trials but also active treatment controlled trials
when available. As a minimum, the exclusion of other
activetreatmentcontrolledtrialsshouldbeexplicitand
with adequate justification.
Someindirectcomparisonsseemedtobedoneonan
ad hoc basis, using data from existing systematic
reviews and meta-analyses. The use of indirect com-
parison should be more systematic in adhering to gen-
erally accepted standards for systematic reviews.
Limitations and implications of the study
Reviewreportscouldbeincludedinthissurveyonlyif
the indirect comparison was explicit in their titles and
abstracts, and if they were indexed in PubMed. Thus
we may have missed many review reports of indirect
comparisons. The use of indirect comparison in possi-
bly missed review reports may have been less explicit
and less formal than review reports included in this
survey, thus not meriting a mention in the abstract. It
is possible that methodological problems would be
more frequent and severe in review reports that were
not identified.
Findings from this study can be used to promote
valid indirect comparisons and to reduce invalid
ones. Box 2 summarises identified methodological
problems in the use of indirect approaches and corre-
spondingrecommendationstoresolvetheseproblems.
However, empirical evidence on the validity of indir-
ectandmixedtreatmentcomparisonisstilllimitedand
manyquestionsremainunanswered.Forexample,itis
unclear whether the assessment of trial similarity and
evidence consistency was appropriately done in the
included review reports. In addition, there is only lim-
ited empirical evidence to show that improved trial
similarityisassociatedwithimprovedvalidityofindir-
ectandmixedtreatmentcomparison.Furtherresearch
is required to answer these questions.
Conclusion
We have identified certain methodological problems
that may invalidate the results of evaluations using
indirect comparison approaches. Adequate under-
standing of basic assumptions underlying indirect and
mixedtreatmentcomparisoniscrucialtoresolvethese
methodological problems.
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